Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Who Will Pay for Prescription Drugs in 2034? Medicare's Surprising Rise in the Latest Government Forecasts

By Adam J. Fein, Ph.D. and Greis Kapexhiu In late June, the boffins at the Centers for Medicare & Medicaid Services (CMS) released the latest projections for U.S. spending more >

The Industry Doesn't Have an Access Collaboration Problem. It Has an Accountability Problem.

Today's guest post comes from Jen Norton, President, Market Access & Value at EVERSANA. Jen examines why fragmented ownership across development, regulatory, pricing, distribution, and field more >